Liver-Assessment Tool Hepatoscope® Steadily Expands Installed-Base Validating Its Clinical and Commercial Viability

AIX-EN-PROVENCE, France--(BUSINESS WIRE)--After successfully exhibiting its unique software-based liver assessment tool Hepatascope at the DDW Convention in San Diego and the EASL Conference in Amsterdam, the France-based medical ultrasound company E-Scopics will demonstrate the technology at the June 2025 American Diabetes Association Conference in Chicago. The technology is seeing expanded adoption, with the company reporting that it has established the technology in a number of important sites in the US and Europe, validating its clinical and commercial viability.
In the span of a few short years, the company has successfully adapted its premium ultrafast imaging point-of-care systems into GI and primary care, putting the system into the hands of a growing number of users who recognize its clinical value and importance in improving the standard of care for patients. In the process, E-Scopics has completely disrupted the field of portable ultrasound by leveraging proprietary technology using software-based image reconstruction. In 2023 E-Scopics began to commercialize its first product, Hepatoscope, both in the USA and in EMEA countries. The company's mid-term goal is to increase its footprint globally, starting its expansion to most European countries, where patients at risk of chronic liver diseases are. Hepatoscope continues to gain recognition as an alternative to legacy technology, from major institutions and all-size healthcare institutions across the USA.
E-Scopics Founder and CEO Claude Cohen-Bacrie, who brings deep experience developing and taking to market cutting-edge ultrasound technologies, commented, 'Our ambition is to bring premium quantitative ultrasound modalities and tools at the point-of-care, in the hands of non-ultrasound expert users, for the benefit of healthcare systems and patients. Making patients' journey and care pathways simpler and more efficient is our priority. We are so pleased that our backers- both leading users who understand the clinical and business partners who get the commercial potential, are in it for the long haul- and really excited about it.'
The company recognized MASLD was on the rise globally, and the need to bring the healthcare community a less expensive, more portable, and easier-to-use tool to accurately screen for the disease. It was very deliberate, developing a tool that was simple to use and reducing costs. The Hepatoscope application can easily be loaded onto a consumer laptop or tablet and rapidly deployed in the field. In addition to ease-of-use, the company saw Ultrasound-as-a-Service model as means to open access to any clinic via an affordable monthly or pay-per-use subscription, innovating on the business side.
Cohen-Bacrie continued, 'We see a healthier patient population coming out of a world where there is healthy business competition which drives innovation. We would not be talking about elastography outside of this important competitive environment. Especially where liver assessment is concerned, patients really need it, clinicians are asking for better and more affordable tools, and the FDA and payers endorse it.'
The numbers bear the need out. Approximately 1.5 million patients have been diagnosed with metabolic dysfunction associated steatohepatitis (MASH) in the U.S., and it is estimated that the precursor to MASH—metabolic dysfunction-associated steatotic liver disease or MASLD—will affect more than half of all American adults by 2040. The MASLD spectrum ranges from a simple, generally nonprogressive fat buildup in the liver all the way to MASH, which can lead to cirrhosis, hepatocellular carcinoma, and death. The economic burden attributed to effects of MASLD in the U.S. exceeds $100 billion annually. Therefore, it is crucial to identify these patients and take care of them as early as possible.
'As consumers we've become conditioned to expect the latest and greatest personal computing and communications tools, they simply make us more efficient in day-to-day tasks, said Dr. Julio Gutierrez, Associate Professor of Medicine at Scripps Center for Organ Transplant in La Jolla, CA and an early adopter of Hepatoscope. 'I think of E-Scopics like Apple and have come to expect continuous innovation, and the clinical impact has been significant.'
Dr. Cyrielle Caussy MD, PhD, Professor of Nutrition and an Endocrinologist-Diabetologist at Lyon 1 University and Lyon South Hospital in France, asserted, 'In the endocrine and diabetology practice, approximately 80% of patients screened show low liver stiffness, which means they can be reassured without further referral or testing. By reducing the time between initial screening and specialty care, the Hepatoscope improves both the efficiency and quality of patient management. For high-risk patients, we can initiate care pathways much earlier, potentially slowing or halting the progression of liver disease. At the same time, for low-risk individuals, we avoid unnecessary referrals, which frees up resources and improves overall healthcare system efficiency. Importantly, patients appreciate the immediate feedback they receive, which encourages compliance with treatment plans and lifestyle modifications.'
E-Scopics will demonstrate Hepatoscope at the American Diabetes Association annual conference in Chicago in Booth #3527. Visitors may walk in and also book a time by emailing joel.gay@e-scopics.com
About E-Scopics:
E-Scopics S.A.S is a MedTech company headquartered in France. The company advances the accessibility, affordability, and ease of use of premium ultrasound tools at the point of care. Its agile software platform has dematerialized and automated ultrasound imaging technologies. Ultrasound-as-a-Service products derived from this platform are specific Apps commercialized with pay-per-use or subscription business models. The company's first product, the Hepatoscope, leverages quantitative imaging capabilities to help any clinician assess liver fibrosis and steatosis—important markers of MASLD-MASH—non-invasively at the bedside. To learn more, visit www.escopics.com.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Washington Post

32 minutes ago

• Washington Post

Land deal ends controversial mining fight near Georgia's Okefenokee Swamp

A contentious, years-long fight over a proposed mine next to one of the South's last truly wild places ended abruptly Friday, when a nonprofit group announced it would spend nearly $60 million to acquire thousands of acres of land near the Okefenokee National Wildlife Refuge in rural Georgia. The Conservation Fund, which works around the country to acquire and protect threatened landscapes, said it had agreed to purchase roughly 7,800 acres from Alabama-based Twin Pines Minerals, as well as the underlying mineral rights. The landmark deal halted a proposed titanium mine on the site, which has been the subject of legal and political fights, as well as sustained criticism from advocacy groups, scientists, lawmakers and other citizens. The opponents argued that mining the mineral-rich area known as Trail Ridge would not only be risky but also environmentally reckless, given its proximity to the largest blackwater swamp in North America. 'This is the most important deal we've worked on,' said Stacy Funderburke, vice president of the central Southeast region for The Conservation Fund, who said the group felt compelled to end the prospect of mining near the Okefenokee. 'It's just a unique place.' Funderburke said the purchase came after about a year of negotiations, and was possible in part because of significant support from a number of individuals and philanthropic groups — including the Holdfast Collective, a nonprofit dedicated to environmental protection and funded by the outdoor gear company Patagonia. Friday's news brought praise — and relief — from activists who had opposed the mine over the past 6 years. 'This is an incredibly special outcome, and there is no place more deserving than the Okefenokee,' Megan Huynh, a senior attorney for the Southern Environmental Law Center, said in a statement Friday. 'Georgians sent a clear message to Twin Pines Minerals that mining next to the Okefenokee is an unacceptable risk. This wouldn't have been possible without a powerful coalition, and regular Georgians who were willing to stand up and defend a place as beloved as the Okefenokee.' The roughly 640-square-mile refuge in southeastern Georgia supports an astounding array of life, from black bears and red-cockaded woodpeckers to thousands of alligators. It is home to black gum trees and carnivorous plants with names such as hooded pitcher and golden trumpet. It is the headwaters for two rivers, the Suwannee and the St. Marys. And its vast peat deposits, formed by the slow decomposition of plants and 15 feet deep in places, store enormous amounts of carbon. Formed by a saucer-shaped depression left behind when the ocean retreated thousands of years ago, the Okefenokee is now a shallow, sprawling, mystical bog, fed almost entirely by rainwater — and a place that draws an estimated 800,000 annual visitors. 'Everything you see around us is old seafloor,' Michael Lusk, who manages the refuge on behalf of the U.S. Fish and Wildlife Service, told The Post during a visit last year. It is also a fragile ecosystem — one that proponents feared could easily be upended by a nearby mining operation. Twin Pines, which in an email declined to comment on Friday's land deal, initially sought permits in 2019 to mine roughly 2,400 acres near the southeastern corner of the swamp. The company later amended its requests and sought to operate on a 582-acre site, vowing that its investment would expand the local tax base and bring hundreds of good-paying jobs to an area where poverty runs deep. The company insisted that its operations to extract titanium dioxide — widely used as a pigment in paints, sunscreens and an array of other products — would not leave a lasting scar on the land or threaten the beloved swamp. It vowed to mine only a small portion at a time, to dig no deeper than 50 feet, and to operate no closer than 2.9 miles from the swamp. Last year, Georgia's Environmental Protection Division issued draft permits that, if finalized, would have allowed the project to move forward. In its responses to the tens of thousands of public comments it had received raising concerns about the mine, the agency wrote in part that it believed the proposed operation 'should have a minimal impact' on the swamp. Such findings did not assuage opponents, who included some local residents, admirers of the swamp far beyond Georgia's borders, and even the Biden administration. During one three-hour public hearing last year, nearly 100 people spoke passionately against the proposed project, as hundreds more listened in. No one spoke in favor. College students, grandparents, scientists, environmental activists, outdoor enthusiasts and local residents issued similar pleas, pleading with state officials to halt the project. They quoted the Bible, the Torah and University of Georgia hydrology findings. They described the Okefenokee as 'majestic,' 'sacred' and 'precious.' They called the idea of mining anywhere near it 'irresponsible,' 'heartbreaking' and 'shortsighted.' On Friday, Funderburke said the land deal should be fully complete by the end of July. Over time, he said, the group plans to manage the site for permanent conservation and allow public access. 'It felt like the most urgent thing was to stop the mining threat, which was imminent,' said Funderburke, who said he has been coming to the swamp each year for decades, often bringing along his daughters. 'There's just no other place like the Okefenokee.' Even as the most recent fight over the swamp's fate ended on Friday, advocates warned that it might not be the last such confrontation. In the 1990s, DuPont pursued plans to mine titanium dioxide across tens of thousands of acres in the area, which is home to significant deposits of titanium dioxide and other minerals. At the time, the federal government joined environmental groups, scientists and local residents to fight the plan. 'Titanium is a common mineral,' Bruce Babbitt, President Bill Clinton's interior secretary, said during a 1997 visit, 'while the Okefenokee is a very uncommon swamp.' DuPont eventually abandoned the project and donated 16,000 acres for conservation. Josh Marks, an environmental attorney who has fought mining near the swamp for decades, called Friday's land deal a 'huge victory' for 'our state's greatest natural treasure.' But, he warned in an email, 'The threat is not over by a long shot.' He implored state lawmakers to finally pass proposed legislation that would safeguard the Okefenokee from future mining, and for the governor to sign it, 'so that we don't have to keep having these fights every 20 years.'

Yahoo

37 minutes ago

• Yahoo

Walmart to pay $10 million to settle US FTC lawsuit over money transfer fraud

By Jonathan Stempel (Reuters) -Walmart has agreed to pay $10 million to settle a U.S. Federal Trade Commission civil lawsuit accusing the world's largest retailer of ignoring warning signs that fraudsters used its money transfer services to fleece consumers out of hundreds of millions of dollars. The settlement was filed on Friday in Chicago federal court, and requires approval by U.S. District Judge Manish Shah. Walmart also agreed not to process money transfers it suspects are fraudulent, or help sellers and telemarketers it believes are using its services to commit fraud. "Electronic money transfers are one of the most common ways that scammers tell consumers to send them money, because once it's sent, it's gone for good," said Christopher Mufarrige, director of the FTC consumer protection bureau. "Companies that provide these services must train their employees to comply with the law and work to protect consumers." The Bentonville, Arkansas-based retailer did not admit or deny wrongdoing in agreeing to settle. Walmart did not immediately respond to requests for comment. In its June 2022 complaint, the FTC accused Walmart of turning a blind eye to fraudsters who used its money transfer services to cash out at its stores. Walmart acts as an agent for money transfers by companies such as MoneyGram, Ria and Western Union. Money can be hard to trace once delivered. The FTC said fraudsters used many schemes that included impersonating Internal Revenue Service agents, impersonating family members who needed money from grandparents to avoid jail, and telling victims they won lotteries or sweepstakes but owed fees to collect their winnings. Shah dismissed part of the FTC case last July but let the regulator pursue the remainder. Walmart appealed from that decision. Friday's settlement would end the appeal. The case is Federal Trade Commission v Walmart Inc, U.S. District Court, Northern District of Illinois, No. 22-03372. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Business Wire

an hour ago

• Business Wire

Ex-Blackstone Investor Raises $7M for Meridian, Private Equity's New AI Operating System

NEW YORK--(BUSINESS WIRE)-- Meridian, the AI-powered deal management platform for the private markets, today announced its $7 million Series Seed fundraise. The round was led by 645 Ventures with participation from existing investor Chaac Ventures. Meridian also welcomed a group of high-impact angel investors – industry leaders from private equity, credit, and M&A law, many of whom have actively shaped Meridian as early users. "Private equity still runs on fragmented, manual systems: clunky software, Excel trackers, and scattered third-party data subscriptions. We're building software that finally reflects how top investment teams source and diligence deals." Founded by Alexander Sen, a former investor at Blackstone, Thoma Bravo, and CVC, Meridian is building the AI operating system for private market investors. The company combines modern CRM with deep workflow automation and proprietary AI agents to solve the core operational pain points of the world's leading investors – from deal origination to exit. 'Private equity still runs on fragmented, manual systems: clunky software, Excel trackers, and scattered third-party data subscriptions,' said Alexander Sen, founder and CEO of Meridian. 'We're building software that finally reflects how top investment teams source and diligence deals – and we've vertically integrated AI to enable workflows that were never possible before.' Meridian brings together a team of over 25 across New York and Miami, with experience spanning enterprise software, AI infrastructure, and capital markets. The company has also hired an experienced customer team who guide firms through the most important technological shift facing private markets today. At the heart of the platform is Scout, Meridian's AI engine. Scout powers intelligent agents that map markets, pinpoint the right companies, automate core evaluation workflows, and surface relationship signals where they matter most. It helps firms spot high-conviction deals before the market does – giving teams a decisive sourcing and diligence edge. Meridian has to date focused on the top of the market, helping some of the world's largest private equity and credit firms run better, more intelligent deal sourcing and evaluation processes. The platform is quickly gaining share at top 100 firms and is now expanding into LPs, investment banks, and global hedge funds – reflecting a broader shift toward modern infrastructure across every layer of private company investing. 'There's a generational shift happening in private markets – more complexity, more competition, and more data,' said Nnamdi Okike, Managing Partner at 645 Ventures. 'AI is a game changer for private market deal sourcing, due diligence and deal management. Firms that do not leverage AI in this new market will be left behind. We were particularly drawn to Alex's insights into how AI will transform private markets, which were developed through his experience in private equity. Meridian is arming investors with the system they'll need to win.' The funding will be used to expand Meridian's AI capabilities, accelerate product development, and scale go-to-market efforts globally. 'Private market firms are under pressure to move faster, operate leaner, and make sharper decisions,' said Sen. 'Software is no longer just overhead at private equity firms – it's become a source of edge. The best investors are treating technology and data as central to how they generate outsized returns.' To request a demo or learn more, visit About Meridian Meridian is the AI-native operating system for institutional private markets. The platform combines next-generation deal software, massive datasets, and intelligent agents into a single system that helps investors originate, evaluate, and execute with greater speed and precision. Founded by Alexander Sen, a former investor at Blackstone, Thoma Bravo, and CVC, Meridian serves private equity, credit, and broader financial services firms engaged in M&A. The company is headquartered in New York and Miami, with a team of product builders, engineers, and customer leaders with deep experience across enterprise software and private markets. Learn more at About 645 Ventures 645 Ventures is an early-stage venture capital firm that partners with exceptional founders building iconic companies. The firm invests at the Seed and Series A stages and supports founders through its proprietary software platform Voyager and deep Connected Network. 645 Ventures manages over $550M in AUM across five funds. Learn more at